157 related articles for article (PubMed ID: 19011669)
1. Intracoronary endothelin receptor blockade improves endothelial function in patients with coronary artery disease.
Böhm F; Jensen J; Svane B; Settergren M; Pernow J
Can J Physiol Pharmacol; 2008 Nov; 86(11):745-51. PubMed ID: 19011669
[TBL] [Abstract][Full Text] [Related]
2. Selective endothelin ETA and dual ET(A)/ET(B) receptor blockade improve endothelium-dependent vasodilatation in patients with type 2 diabetes and coronary artery disease.
Rafnsson A; Shemyakin A; Pernow J
Life Sci; 2014 Nov; 118(2):435-9. PubMed ID: 24607773
[TBL] [Abstract][Full Text] [Related]
3. Endogenous endothelin in human coronary vascular function: differential contribution of endothelin receptor types A and B.
Halcox JP; Nour KR; Zalos G; Quyyumi AA
Hypertension; 2007 May; 49(5):1134-41. PubMed ID: 17353514
[TBL] [Abstract][Full Text] [Related]
4. Enhanced endothelium-dependent vasodilatation by dual endothelin receptor blockade in individuals with insulin resistance.
Shemyakin A; Böhm F; Wagner H; Efendic S; Båvenholm P; Pernow J
J Cardiovasc Pharmacol; 2006 Mar; 47(3):385-90. PubMed ID: 16633080
[TBL] [Abstract][Full Text] [Related]
5. Endothelin receptor blockade improves endothelial function in atherosclerotic patients on angiotensin converting enzyme inhibition.
Böhm F; Beltran E; Pernow J
J Intern Med; 2005 Mar; 257(3):263-71. PubMed ID: 15715683
[TBL] [Abstract][Full Text] [Related]
6. Inhomogeneous vasomotor effects of moderate selective and non-selective endothelin-receptor blockade in stable coronary artery disease.
Wexberg P; Sperker W; Morgenthaler NG; Heinzl H; Adlbrecht C; Plass C; Glogar HD; Lang IM; Neunteufl T
Heart; 2009 Aug; 95(15):1258-64. PubMed ID: 19414437
[TBL] [Abstract][Full Text] [Related]
7. Dual endothelin receptor blockade acutely improves insulin sensitivity in obese patients with insulin resistance and coronary artery disease.
Ahlborg G; Shemyakin A; Böhm F; Gonon A; Pernow J
Diabetes Care; 2007 Mar; 30(3):591-6. PubMed ID: 17327326
[TBL] [Abstract][Full Text] [Related]
8. Endothelin-A and -B antagonists protect myocardial and endothelial function after ischemia/reperfusion in a rat heart transplantation model.
Szabó G; Fazekas L; Bährle S; MacDonald D; Stumpf N; Vahl CF; Hagl S
Cardiovasc Res; 1998 Sep; 39(3):683-90. PubMed ID: 9861312
[TBL] [Abstract][Full Text] [Related]
9. Effects of antagonists for endothelin ET(A) and ET(B) receptors on coronary endothelial and myocardial function after ischemia-reperfusion in anesthetized goats.
Climent B; Fernández N; García-Villalón AL; Monge L; Sánchez A; Diéguez G
Vascul Pharmacol; 2006 May; 44(5):384-90. PubMed ID: 16580265
[TBL] [Abstract][Full Text] [Related]
10. Endothelin B receptor antagonist increases preproendothelin-1 transcription in bovine aortic endothelial cells and in vivo.
Peled M; Shaish A; Frishman L; Cohen H; Tal R; Harats D
J Cardiovasc Pharmacol; 2006 May; 47(5):668-72. PubMed ID: 16775506
[TBL] [Abstract][Full Text] [Related]
11. Endothelin-1 and ET receptors impair left ventricular function by mediated coronary arteries dysfunction in chronic intermittent hypoxia rats.
Wang JW; Li AY; Guo QH; Guo YJ; Weiss JW; Ji ES
Physiol Rep; 2017 Jan; 5(1):. PubMed ID: 28057852
[TBL] [Abstract][Full Text] [Related]
12. Coronary vasodilation and improvement in endothelial dysfunction with endothelin ET(A) receptor blockade.
Halcox JP; Nour KR; Zalos G; Quyyumi AA
Circ Res; 2001 Nov; 89(11):969-76. PubMed ID: 11717152
[TBL] [Abstract][Full Text] [Related]
13. Endothelin B receptors preserve renal blood flow in a normotensive model of endotoxin-induced acute kidney dysfunction.
Nitescu N; Grimberg E; Ricksten SE; Herlitz H; Guron G
Shock; 2008 Mar; 29(3):402-9. PubMed ID: 17693943
[TBL] [Abstract][Full Text] [Related]
14. ETA receptors mediate vasoconstriction, whereas ETB receptors clear endothelin-1 in the splanchnic and renal circulation of healthy men.
Böhm F; Pernow J; Lindström J; Ahlborg G
Clin Sci (Lond); 2003 Feb; 104(2):143-51. PubMed ID: 12546636
[TBL] [Abstract][Full Text] [Related]
15. Physiological role of endothelin-1 in flow-mediated vasodilatation in humans and impact of cardiovascular risk factors.
Bellien J; Iacob M; Monteil C; Rémy-Jouet I; Roche C; Duflot T; Vendeville C; Gutierrez L; Thuillez C; Richard V; Joannidès R
J Hypertens; 2017 Jun; 35(6):1204-1212. PubMed ID: 28441692
[TBL] [Abstract][Full Text] [Related]
16. Endothelin-1 inhibits endothelium-dependent vasodilatation in the human forearm: reversal by ETA receptor blockade in patients with atherosclerosis.
Böhm F; Ahlborg G; Pernow J
Clin Sci (Lond); 2002 Mar; 102(3):321-7. PubMed ID: 11869173
[TBL] [Abstract][Full Text] [Related]
17. Combined endothelin receptor blockade evokes enhanced vasodilatation in patients with atherosclerosis.
Böhm F; Ahlborg G; Johansson BL; Hansson LO; Pernow J
Arterioscler Thromb Vasc Biol; 2002 Apr; 22(4):674-9. PubMed ID: 11950709
[TBL] [Abstract][Full Text] [Related]
18. Endothelin-1 increases superoxide production in human coronary artery bypass grafts.
Cerrato R; Cunnington C; Crabtree MJ; Antoniades C; Pernow J; Channon KM; Böhm F
Life Sci; 2012 Oct; 91(13-14):723-8. PubMed ID: 22483692
[TBL] [Abstract][Full Text] [Related]
19. Effects of phosphoramidon, BQ 788, and BQ 123 on coronary and cardiac dysfunctions of the failing hamster heart.
Fontaine ER; Viau S; Jasmin G; Dumont L
J Cardiovasc Pharmacol; 1998 Jul; 32(1):12-20. PubMed ID: 9676715
[TBL] [Abstract][Full Text] [Related]
20. A causal role for endothelin-1 in the vascular adaptation to skeletal muscle deconditioning in spinal cord injury.
Thijssen DH; Ellenkamp R; Kooijman M; Pickkers P; Rongen GA; Hopman MT; Smits P
Arterioscler Thromb Vasc Biol; 2007 Feb; 27(2):325-31. PubMed ID: 17122448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
